XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.bigmoleculewatch.com/2016/11/30/the-21st-century-cures-act-on-the-verge-of-passage/20%Monthly2016-11-30 22:45
https://www.bigmoleculewatch.com/2016/11/30/interim-response-to-cp-on-interchangeability/20%Monthly2018-01-10 22:00
https://www.bigmoleculewatch.com/2016/11/30/success-for-pfizers-trastuzumab-biosimilar-in-phase-3-clinical-trials/20%Monthly2018-01-10 22:00
https://www.bigmoleculewatch.com/2016/11/29/coherus-announces-marketing-authorization-application-to-the-ema-for-pegfilgrastim-biosimilar/20%Monthly2018-01-10 21:59
https://www.bigmoleculewatch.com/2016/11/29/momenta-announces-positive-phase-iii-results-for-its-humira-biosimilar/20%Monthly2018-01-10 21:58
https://www.bigmoleculewatch.com/2016/11/29/dct-stays-lawsuit-against-hyclone/20%Monthly2018-01-10 21:58
https://www.bigmoleculewatch.com/2016/11/23/regulatory-news-roundup/20%Monthly2018-01-10 21:55
https://www.bigmoleculewatch.com/2016/11/23/sandoz-etanercept-biosimilar-switch-has-no-impact-on-safety-and-efficacy/20%Monthly2018-01-10 21:54
https://www.bigmoleculewatch.com/2016/11/23/bpcia-litigation-roundup-fall-2016/20%Monthly2018-05-25 19:03
https://www.bigmoleculewatch.com/2016/11/22/apotex-files-reply-in-support-of-its-petition-for-certiorari/20%Monthly2018-06-04 15:03
https://www.bigmoleculewatch.com/2016/11/22/tpp-update-president-elect-to-issue-notification-of-withdrawl-from-the-tpp/20%Monthly2016-11-22 19:02
https://www.bigmoleculewatch.com/2016/11/21/scheduling-order-entered-in-abbvie-v-amgen/20%Monthly2018-05-25 18:59
https://www.bigmoleculewatch.com/2016/11/18/regulators-talk-intl-biosimilar-regs-guidance-may-slip-2017/20%Monthly2016-12-15 22:42
https://www.bigmoleculewatch.com/2016/11/17/will-president-elect-trump-and-the-republican-led-congress-repeal-the-bpcia/20%Monthly2019-04-01 14:00
https://www.bigmoleculewatch.com/2016/11/16/bi-phase-i-bevacizumab/20%Monthly2018-01-10 21:46
https://www.bigmoleculewatch.com/2016/11/16/amgen-allergan-bevacizumab-bla/20%Monthly2018-01-10 21:45
https://www.bigmoleculewatch.com/2016/11/15/mylan-and-mabion-reach-agreement-on-rituximab-biosimilar/20%Monthly2018-01-10 21:44
https://www.bigmoleculewatch.com/2016/11/14/celltrion-publishes-data-on-ct-p10-rituximab-and-ct-p13-infliximab/20%Monthly2018-05-25 18:59
https://www.bigmoleculewatch.com/2016/11/11/eagle-pharmaceuticals-to-acquire-arsia-therapeutics/20%Monthly2018-01-10 21:43
https://www.bigmoleculewatch.com/2016/11/11/chmp-recommends-approval-of-three-biosimilars-to-ema/20%Monthly2018-01-10 21:42
https://www.bigmoleculewatch.com/2016/11/11/big-molecule-team-at-2016-bio-ipcc-fall-conference/20%Monthly2017-05-15 17:18
https://www.bigmoleculewatch.com/2016/11/11/amgen-files-opposition-to-apotexs-petition-for-certiorari/20%Monthly2018-05-25 18:58
https://www.bigmoleculewatch.com/2016/11/11/update-obamacare-and-tpp/20%Monthly2017-05-15 17:21
https://www.bigmoleculewatch.com/2016/11/10/survey-finds-need-for-biosimilars-education/20%Monthly2016-11-10 00:04
https://www.bigmoleculewatch.com/2016/11/09/will-trumps-election-impact-the-bpcia/20%Monthly2016-11-09 15:56
https://www.bigmoleculewatch.com/2016/11/09/mylan-and-biocon-partnership-updates/20%Monthly2018-01-10 21:39
https://www.bigmoleculewatch.com/2016/11/08/ptab-denies-institution-of-ipr-on-humira-patent/20%Monthly2018-01-10 21:38
https://www.bigmoleculewatch.com/2016/11/08/fda-approves-expanded-use-of-enbrel/20%Monthly2018-01-10 21:38
https://www.bigmoleculewatch.com/2016/11/07/janssen-v-celltrion-appeal-docketed/20%Monthly2018-05-25 18:57
https://www.bigmoleculewatch.com/2016/11/04/fda-has-accepted-genentechs-bla-for-subcutaneous-rituximab/20%Monthly2018-01-10 21:37
https://www.bigmoleculewatch.com/2016/11/04/hospira-files-responsive-appeal-brief-in-amgen-v-hospira-litigation/20%Monthly2018-05-25 18:56
https://www.bigmoleculewatch.com/2016/11/02/pfizer-discontinues-development-of-lipid-lowering-drug-bococizumab/20%Monthly2018-01-10 21:36
https://www.bigmoleculewatch.com/2016/11/02/boehringer-ingelheim-announces-positive-phase-iii-results-for-its-humira-biosimilar-candidate/20%Monthly2018-01-10 21:35
https://www.bigmoleculewatch.com/2016/11/01/celltrions-herceptin-biosimilar-submitted-for-approval-in-europe/20%Monthly2018-01-10 21:34